Search

everythinglearnresearchcommunity

for

Search:↓

Hairless mice lack fur due to a genetic mutation affecting skin response, not hormone issues.

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

Bio-fortification through plant breeding can improve the nutritional value of staple crops by adding essential minerals.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Improved dermabrasion techniques in 1987 led to better treatment results for skin issues like acne scars.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Finasteride shows promise for female hair loss, but more research needed.

STAT5 activation is crucial for starting the hair growth phase.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

The gene p53 is crucial for removing damaged cells to allow for healthy tissue renewal.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

New compounds were found to help increase hair growth and decrease hair loss.

3-Deoxysappanchalcone helps human hair cells grow and stimulates hair growth in mice by affecting certain cell signaling pathways.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Using neurohormones to control keratin can lead to new skin disease treatments.

Treatment during development affects hormone balance and sexual behavior in male rats.

Researchers found that certain RNA molecules might play a role in the growth of Cashmere goat hair.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.